# A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant

> **NCT05997459** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 23 (estimated)

## Conditions studied

- Locally Advanced Unresectable Gastric Cancer

## Interventions

- **DRUG:** Pemigatinib

## Key facts

- **NCT ID:** NCT05997459
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-25
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05997459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05997459, "A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05997459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*